Quadrant Private Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,377
Closed -$5.47M 233
2026
Q1
$5.47M Buy
22,377
+109
+0.5% +$25.4K 0.85% 26
2025
Q4
$4.61M Buy
22,268
+164
+0.7% +$32.4K 0.76% 32
2025
Q3
$4.1M Buy
22,104
+65
+0.3% +$11.1K 0.75% 34
2025
Q2
$3.37M Sell
22,039
-1,058
-5% -$163K 0.7% 37
2025
Q1
$3.83M Sell
23,097
-1,421
-6% -$222K 0.95% 29
2024
Q4
$3.55M Sell
24,518
-752
-3% -$117K 0.87% 28
2024
Q3
$4.1M Sell
25,270
-297
-1% -$47.3K 1.01% 24
2024
Q2
$3.74M Buy
25,567
+480
+2% +$71.4K 0.86% 28
2024
Q1
$3.97M Sell
25,087
-974
-4% -$155K 1% 22
2023
Q4
$4.08M Buy
26,061
+455
+2% +$69.8K 1.13% 19
2023
Q3
$3.99M Sell
25,606
-1,852
-7% -$306K 1.34% 16
2023
Q2
$4.54M Buy
27,458
+283
+1% +$45.7K 1.32% 16
2023
Q1
$4.21M Buy
27,175
+41
+0.2% +$6.62K 1.31% 16
2022
Q4
$4.79M Buy
+27,134
New +$4.69M 1.61% 9
2022
Q2
$4.76M Sell
26,809
-1
-0% -$178 1.95% 7
2022
Q1
$4.75M Buy
26,810
+1,396
+5% +$238K 1.77% 11
2021
Q4
$4.35M Buy
25,414
+512
+2% +$83.8K 1.62% 13
2021
Q3
$4.02M Sell
24,902
-136
-0.5% -$23.2K 1.66% 9
2021
Q2
$4.13M Buy
25,038
+351
+1% +$58.1K 1.67% 10
2021
Q1
$4.06M Sell
24,687
-829
-3% -$134K 1.76% 11
2020
Q4
$4.02M Sell
25,516
-174
-0.7% -$25.7K 1.79% 10
2020
Q3
$3.83M Buy
25,690
+1,026
+4% +$152K 1.92% 10
2020
Q2
$3.47M Buy
24,664
+106
+0.4% +$15.4K 2% 9
2020
Q1
$3.22M Buy
24,558
+785
+3% +$111K 2.69% 8
2019
Q4
$3.47M Sell
23,773
-1,370
-5% -$186K 3.1% 7
2019
Q3
$3.25M Sell
25,143
-1,924
-7% -$253K 2.99% 8
2019
Q2
$3.77M Sell
27,067
-70
-0.3% -$9.69K 3.44% 7
2019
Q1
$3.79M Buy
27,137
+111
+0.4% +$14.9K 3.49% 7
2018
Q4
$3.49M Sell
27,026
-132
-0.5% -$18.4K 3.71% 7
2018
Q3
$3.75M Buy
27,158
+432
+2% +$57.4K 3.3% 6
2018
Q2
$3.24M Sell
26,726
-61
-0.2% -$7.61K 3.16% 7
2018
Q1
$3.43M Buy
26,787
+2,728
+11% +$369K 4.49% 6
2017
Q4
$3.36M Buy
+24,059
New +$3.35M 3.5% 8

Other funds holding JNJ

Quadrant Private Wealth Management's JNJ Position: Q2 2026 in Review

Quadrant Private Wealth Management sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 22,377 shares — an estimated $5.47M sold.

Quadrant Private Wealth Management first reported a position in JNJ in Q4 2017 and held it in 33 quarters. The position peaked at $5.47M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Quadrant Private Wealth Management reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Quadrant Private Wealth Management sold 22,377 Johnson & Johnson shares in Q2 2026, an estimated $5.47M.
  • Quadrant Private Wealth Management first reported a position in Johnson & Johnson in Q4 2017 and held it in 33 quarters.
  • Quadrant Private Wealth Management's Johnson & Johnson position peaked at $5.47M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.